1. Maggio CA, Pi-Sunyer FX. Obesity and type 2 diabetes. Endocrinol Metab Clin 2003; 32(4): 805-22. doi:10.1016/S0889-8529(03)00071-9 PMid:14711063

2. Olefsky JM, Kolterman OG, Scarlett JA. Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus. Am J Physiol Endocrinol Metab 1982; 243(1): E15-E30.doi:10.1152/ajpendo.1982.243.1.E15 PMid:7046470

3. Leung PS, De Gasparo M. Involvement of the pancreatic renin‐angiotensin system in insulin resistance and the metabolic syndrome. J Cardiometabolic Syndr 2006;1(3):197-203. doi:10.1111/j.1559-4564.2006.05460.x PMid:17679833

4. Bulum T, Kolarić B, Duvnjak L, Duvnjak M. Nonalcoholic fatty liver disease markers are associated with insulin resistance in type 1 diabetes. Dig Dis Sci 2011; 56: 3655-63.doi:10.1007/s10620-011-1807-7 PMid:21735081

5. Hatting M, Tavares CD, Sharabi K, Rines AK, Puigserver P. Insulin regulation of gluconeogenesis. Ann New York Academy Sci 2018; 1411(1):21-35.doi:10.1111/nyas.13435 PMid:28868790 PMCid:PMC5927596

6. Paz Ocaranza M, Riquelme JA, García L, Jalil JE, Chiong M, Santos RA, Lavandero S. Counter-regulatory renin-angiotensin system in cardiovascular disease. Nat Rev Cardiol 2020;17(2):116-29.doi:10.1038/s41569-019-0244-8,PMid:31427727 PMCid:PMC7097090

7. Silva-Velasco DL, Beltran-Ornelas JH, Tapia-Martínez J, Sánchez-López A, de la Cruz SH, Cervantes-Pérez LG, et al. NaHS restores the vascular alterations in the renin-angiotensin system induced by hyperglycemia in rats. Peptides 2023; 164: 171001. doi:10.1016/j.peptides.2023.171001 PMid:36990388

8. Gillespie EL, White CM, Kardas M, Lindberg M, Coleman CI. The impact of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes. Diabetes Care 2005; 28(9): 2261-6. doi:10.2337/diacare.28.9.2261 PMid:16123505

9. Santos SHS, Braga JF, Mario EG, Pôrto LCJ, Rodrigues-Machado MdG, Murari A, et al. Improved lipid and glucose metabolism in transgenic rats with increased circulating angiotensin-(1-7). Arterioscler Thromb Vasc Biol 2010; 30(5): 953-61. doi:10.1161/ATVBAHA.109.200493 PMid:20203301

10. Cao X, Yang FY, Xin Z, Xie RR, Yang JK. The ACE2/Ang-(1-7)/Mas axis can inhibit hepatic insulin resistance. Mol Cell Endocrinol 2014; 393(1-2): 30-8. doi:10.1016/j.mce.2014.05.024 PMid:24911884

11. de Assis Petriz B, Alves de Almeida J, Migliolo L, Luiz Franco O. Pharmacological potential of exercise and RAS vasoactive peptides for prevention of diseases. Curr Protein Peptide Sci 2013; 14(6): 459-71. doi:10.2174/13892037113149990063 PMid:23968354

12. Kazeminasab F, Marandi SM, Baharlooie M, Nasr-Esfahani MH, Ghaedi K. Modulation and bioinformatics screening of hepatic mRNA-lncRNAs (HML) network associated with insulin resistance in prediabetic and exercised mice. Nutr Metab 2021; 18(1): 1-16. doi:10.1186/s12986-021-00600-0, PMid:34284789 PMCid:PMC8290563

13. Tonne JM, Sakuma T, Munoz-Gomez M, El Khatib M, Barry MA, Kudva YC, Ikeda Y. Beta cell regeneration after single-round immunological destruction in a mouse model. Diabetologia 2015; 58: 313-23. doi:10.1007/s00125-014-3416-4, PMid:25338552 PMCid:PMC4287683

14. Powers SK, Criswell D, Lawler J, Martin D, Lieu F-K, Ji LL, Herb RA. Rigorous exercise training increases superoxide dismutase activity in ventricular myocardium. Am J Physiol Heart Circ Physiol 1993; 265(6): H2094-H8. doi:10.1152/ajpheart.1993.265.6.H2094 PMid:8285249

15. Gaeini A, Ramezani N, Shafiei Neek L. Changes of LXR α, GLUT2 genes expression in liver and insulin resistance after aerobic training in type 2 diabetic rats. Metab Exerc 2019; 9(1): 1-13.

16. Kirwan JP, Sacks J, Nieuwoudt S. The essential role of exercise in the management of type 2 diabetes. Cleve Clin J Med 2017; 84(7 Suppl 1): S15.doi:10.3949/ccjm.84.s1.03, PMid:28708479 PMCid:PMC5846677

17. Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 2005; 54(3): 603-8. doi:10.2337/diabetes.54.3.603, PMid:15734833 PMCid:PMC2995496

18. Magnusson I, Rothman D, Katz L, Shulman R, Shulman G. Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. J Clin Investig 1992; 90(4): 1323-7.doi:10.1172/JCI115997 PMid:1401068 PMCid:PMC443176

19. Kirwan JP, Solomon TP, Wojta DM, Staten MA, Holloszy JO. Effects of 7 days of exercise training on insulin sensitivity and responsiveness in type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 2009. doi:10.1152/ajpendo.00210.2009, PMid:19383872 PMCid:PMC2711659

20. Henriksen EJ. Improvement of insulin sensitivity by antagonism of the renin-angiotensin system. Am J Physiol Regulatory Integr Comparative Physiol 2007. doi:10.1152/ajpregu.00147.2007 PMid:17581838

21. Lin X, Zhang X, Guo J, Roberts CK, McKenzie S, Wu WC, et al. Effects of exercise training on cardiorespiratory fitness and biomarkers of cardiometabolic health: a systematic review and meta‐analysis of randomized controlled trials. J Am Heart Association 2015; 4(7): e002014. doi:10.1161/JAHA.115.002014 PMid:26116691 PMCid:PMC4608087

22. Zheng H, Sharma NM, Liu X, Patel KP. Exercise training normalizes enhanced sympathetic activation from the paraventricular nucleus in chronic heart failure: role of angiotensin II. Am J Physiol Regulatory Integr Comparative Physiol 2012; 303(4): R387-R94. doi:10.1152/ajpregu.00046.2012, PMid:22718804 PMCid:PMC3423995

23. Silva Jr SD, Zampieri TT, Ruggeri A, Ceroni A, Aragão DS, Fernandes FB, et al. Downregulation of the Vascular Renin-Angiotensin System by Aerobic Training-Focus on the Balance between Vasoconstrictor and Vasodilator Axes-. Circulation J 2015; 79(6): 1372-80. doi:10.1253/circj.CJ-14-1179, PMid:25808225

24. Chu KY, Lau T, Carlsson PO, Leung PS. Angiotensin II type 1 receptor blockade improves β-cell function and glucose tolerance in a mouse model of type 2 diabetes. Diabetes 2006; 55(2): 367-74. doi:10.2337/diabetes.55.02.06.db05-1022 PMid:16443769

25. Barton M, Carmona R, Ortmann J, Krieger JE, Traupe T. Obesity-associated activation of angiotensin and endothelin in the cardiovascular system. Int J Biochemistry Cell Biol 2003; 35(6): 826-37. doi:10.1016/S1357-2725(02)00307-2 PMid:12676169

26. Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Pettiti M, Natali A, et al. Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance. Diabetologia 2003; 46: 1211-9. doi:10.1007/s00125-003-1169-6 PMid:12879253

27. Prasannarong M, Santos FR, Henriksen EJ. ANG-(1-7) reduces ANG II-induced insulin resistance by enhancing Akt phosphorylation via a Mas receptor-dependent mechanism in rat skeletal muscle. Biochem Biophysical Res Communications 2012; 426(3): 369-73. doi:10.1016/j.bbrc.2012.08.093 PMid:22960175

28. Gomes-Santos IL, Fernandes T, Couto GK, Ferreira-Filho JCA, Salemi VMC, Fernandes FB, et al. Effects of exercise training on circulating and skeletal muscle renin-angiotensin system in chronic heart failure rats. PLoS One 2014; 9(5): e98012. doi:10.1371/journal.pone.0098012 PMid: 24859374 PMCid:PMC4032232

29. Magalhães DM, Nunes-Silva A, Rocha GC, Vaz LN, de Faria MHS, Vieira ELM, et al. Two protocols of aerobic exercise modulate the counter-regulatory axis of the renin-angiotensin system. Heliyon 2020; 6(10): e05256. doi:10.1016/j.heliyon.2020.e05256, PMid:33134578 PMCid:PMC7586090

30. Evangelista FS. Physical exercise and the renin angiotensin system: prospects in the COVID-19. Frontiers Physiol 2020; 11: 561403 doi:10.3389/fphys.2020.561403 PMid:33178033 PMCid:PMC7593780